Comment on Nannini LJ (2013): Combined corticosteroid and long-acting beta₂-agonist in one inhaler versus placeb https://t.co/mMRE8FFU5F
Combined inhaler reduced #COPD flare-ups by a quarter, compared with placebo http://t.co/lBKDyjOs3f #WorldCOPDDay #CochraneEvidence
Combined inhaler reduced #COPD flare-ups by a quarter, compared with placebo http://t.co/lBKDyjOs3f #WorldCOPDDay #CochraneEvidence
Combined inhaler reduced #COPD flare-ups by a quarter, compared with placebo http://t.co/lBKDyjOs3f #WorldCOPDDay #CochraneEvidence
Combined inhaler reduced #COPD flare-ups by a quarter, compared with placebo http://t.co/lBKDyjOs3f #WorldCOPDDay #CochraneEvidence
Felicitaciones DR. Nannini por la excelente revisión Cochrane sobre corticoides inhalados en EPOC. http://t.co/QEqwUTevyO
Felicitaciones DR. Nannini por la excelente revisión Cochrane sobre corticoides inhalados en EPOC. http://t.co/QEqwUTevyO
#Cochrane just updated review of #ICS/LABA v placebo for #COPD. #Xenhale trials now in but add nothing new. http://t.co/7w5G0fy8cn
#CochraneEvidence finds fewer hospital admissions but increased risk of pneumonia with combo inhalers in #COPD http://t.co/TnIGD5uCfR